Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 28 Feb 2022 Conference abstract · 22 Jun 2020 Synthesis of 2-arylmethylthio-4-benzyl-5-methylimidazoles as anti-metastatic drug candidates through the inhibition of STAT3-SH2 pathway
clearly indicate that 2a and 2d may serve as promising lead compounds as anti-metastatic STAT3-SH2 inhibitors
Conference abstract · 18 Mar 2020 Active specific immunotherapy (ASI) and GcMAF Forte in management of metastatic invasive carcinoma–overview of the therapeutic modalities and a case report
Metastatic cancer is often a fatal disease with low survival rate that in a course of its progression implies a pathogenic cascade involving inflammation, overexpression of reactive oxygen species, loss ... cancer. The…
Conference abstract · 23 Sep 2019 Local treatment of metastatic squamous cell carcinoma on the medial aspect of the mandibular ramus using for the first time cryosurgery
whole oral cavity. Oral region metastases are considered uncommon. The most frequent sources of metastatic tumors to the mouth are primary cancers from the lung and breast with the latter ... this lecture is to present…
Conference abstract · 14 Aug 2019 Rare Occurrence of Concomitant Brain Tumor Hemorrhages and Infarctions in a Patient with Metastatic Testicular Choriocarcinoma: a Case Report and Review of Literature
also cerebral infarctions of varying ages on cranial imaging. Further workup also demonstrated metastatic lesions to the lungs and liver. Despite treatment with Cisplatin based systemic chemotherapy, he succumbed…
Conference abstract · 2019 Efficacy of oral immunotherapy in a case of metastatic breast cancer
clinical trials. Many studies have been conducted in relation to the treatment of metastatic breast cancer with immunotherapy but the possibility of emergence of alternate effects has also not been ... report aims to…
Conference abstract · 2019 Hormone immunotherapy in endocrine dependent metastatic breast cancer patients
Insoluble and inactive protein aggregates known Hormone therapy is advised for ER+ metastatic breast cancer patients due to its efficacy concomitant with low toxicity; however, in most patients the occurrence
Conference abstract · 27 Dec 2018 GRP52 is a new sensitive markers for detecting metastatic prostatic carcinoma
Metastatic prostate cancer is frequently presented as cancer of unknown origin. To confirm the prostatic origin, prostatespecific antigen (PSA), prostein, HoxB13, and NKX3.1 are frequently used. However, these markers…
Conference abstract · 7 Dec 2018 A Case of Metastatic Lung Cancer in Scalp Mimicking Variant Sarcoma
histopathologic findings using special staining (thyroid transcription factor-1, napsin) showed a lung-derived metastatic adenocarcinoma. His condition was confirmed with multiple metastases after systemic examinations…
Conference abstract · 6 Dec 2018 Outcomes of Locoregional Therapy for Metastatic Gastric Cancer; A National Cancer Database Analysis
Background: Patients with metastatic gastric cancer have poor survival. The purpose of this study was to compare outcomes of metastatic gastric cancer patients with or without surgery and radiation therapy…
Research article · 10 Sep 2018 Research on the treatment of metastatic colon cancer patients treated by FOLFOXIRI: Efficacy and toxicity of first-line treatment in stage IV metastatic colorectal cancer patients
Background: In recent years, the new trend in treatment of colorectal cancer
Conference abstract · 10 May 2018 Pre-metastatic rearrangement of lungs function – proteomic characterization of metastatic niche formation
Metastases are the major cause of high mortality in patients with cancer. Lung metastatic niche facilitate the process of cancer cells survival in a foreign microenvironment and enables their protection ... profiling of…
Conference abstract · 10 May 2018 A predictive model to identify who would benefit from primary tumor surgery among patients with metastatic breast cancer at diagnosis: a population-based analysis
Purpose: the prognostic role of primary tumor surgery among female patients with metastatic breast cancer is controversial. We ought to investigate whether primary tumor surgery can improve the overall survival…
Conference abstract · 20 Apr 2018 Cardiac toxicity risk of long-term use of trastuzumab in metastatic breast cancer: The importance of a cardio-oncology team
effects of trastuzumab are probably overemphasized. I report the case of a woman with metastatic breast cancer, who is currently in complete remission, and who was treated with trastuzumab
Conference abstract · 12 Mar 2018 Ten-year outcome study in a cohort of non-metastatic renal cell carcinoma treated with curative intent at SKCH & RC: survival and progression after radical nephrectomy in 344 patients
Background: Radical nephrectomy (RN) is a standard treatment of cure for non-metastatic renal cell carcinoma (NMRCC). Long-term outcome data are limited for Pakistani population ... grade, and early postoperative…
Conference abstract · 2018 Early Vertebroplasty for Spinal Metastatic Pain and Metastatic Fractures
Conference abstract · 14 Dec 2017 Unique case of retroperitoneal fibrosis masking a metastatic adenocarcinoma of unknown origin
ominous prognosis. We present the first reported case of retroperitoneal fibrosis related to metastatic adenocarcinoma of a primary occult tumor. This is a 64-year-old Caucasian male presented ... colon with wall…
Conference abstract · 13 Nov 2017 Cost analysis of metastatic non-small cell lung cancer (NSCLC) after completion of chemotherapy with the introduction of erlotinib
examining population-based total costs, service utilization, and clinical outcomes of patients with metastatic NSCLC receiving Erlotinib were explored from the time they completed chemotherapy till the end of follow…
Conference abstract · 2 Nov 2017 Hormone-immunotherapy in endocrine-dependent metastatic breast cancer and serum biomarkers
Hormone therapy is currently advised for ER+ metastatic breast cancer patients; however in most of them the arising of resistance is a not yet well understood hurdle to overcome
Conference abstract · 17 Jul 2017 Chimeric antigen receptor modified T cell redirected to EGFR in patients with metastatic and advanced pancreatic adenocarcinoma and biliary tract cancers
Statement of the Problem: Limited effective treatment opinions and dismal prognosis in metastatic pancreatic adenocarcinoma (mPA) and biliary tract cancers (BTCs) require developing novel therapeutic approaches…
Conference abstract · 29 May 2017 Bone Microenvironment Targeted Nanoparticles for Metastatic Prostate Cancer Treatment
Purpose The most common site of metastatic prostate cancer is the bone. These metastatic lesions are difficult to treat and often result in off target cytotoxicity from current chemotherapeutics ... tumor spheroids…
Case report · 2017 Eleven-Year Survival with Unresectable Metastatic Pancreatic Carcinoma: A Roadmap to Long-term Survival for Metastatic Disease
lymph node who is now over 11 years out from her original diagnosis of metastatic disease. This report describes the methodology of the patient’s treatment including
Conference abstract · 21 Jul 2016 Targeting the Microenvironment for Therapy of Primary and Metastatic Brain Tumors
rnThe median survival of patients with the primary or metastatic brain tumor is limited due to resistance to all standard therapies. The mechanism of pan-resistance against the systemic therapy ... into the preclinical…
Conference abstract · 30 Jun 2016 Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer – case report
therefore, their presence could help in the diagnosis of the primary site of a metastatic tumor. Case presentation: In this article, the authors present a patient 58-year ... with metastatic adenocarcinoma, in whom…
Conference abstract · 30 Jun 2016 Toward full understanding of the EPR effect in primary and metastatic tumor, and issues of heterogeneity: For tumor selective delivery and imaging using nano-particles
inflammation, eg. bradykinin, nitric oxide, etc. EPR effect was also demonstrated in metastatic cancers recently. Heterogeneity of EPR in many tumors may be caused by tumor thrombus or suppressed blood

